Research progress on coronary heart disease and cytokines: mechanisms, clinical implications, and future directions

Area of Science:

• Cardiovascular Medicine
• Immunology
• Molecular Biology

Background:

• Coronary heart disease (CHD) is a leading cause of mortality, with inflammation as a central pathogenic mechanism.
• Cytokines, crucial immune response mediators, significantly influence CHD progression.
• Cytokines regulate key processes including myocardial apoptosis, endothelial dysfunction, and vascular smooth muscle cell proliferation.

Purpose of the Study:

• To provide a comprehensive overview of cytokines' roles in coronary heart disease.
• To elucidate the specific effects of pro-inflammatory and anti-inflammatory cytokines on atherosclerosis and cardiomyocyte function.
• To discuss the clinical utility of cytokines in CHD risk stratification, prognosis, and therapeutic strategies.

Main Methods:

• Literature review of existing research on cytokines and CHD.
• Analysis of cytokine functions in cardiovascular pathophysiology.
• Exploration of clinical applications and future research directions.

Main Results:

• Pro-inflammatory cytokines (TNF-α, IL-1, IL-6) exacerbate atherosclerosis and impair cardiomyocyte function.
• Anti-inflammatory cytokines (IL-10, TGF-β) play protective roles in cardiovascular disease.
• Cytokines demonstrate clinical value in assessing CHD risk, predicting outcomes, and guiding targeted treatments.

Conclusions:

• Cytokines are critical players in CHD pathogenesis and progression.
• Targeting specific cytokines offers potential for novel therapeutic interventions in cardiovascular disease.
• Further research, utilizing advanced technologies, is needed for personalized CHD therapies.